Changes big and small can benefit those of us with MASH
As leaves fall from the trees, columnist Kathryn Hudson celebrates the changes, both big and small, that have improved her health with MASH.| Liver Disease News
A family whose experience with biliary atresia led to an effort to help others navigate the challenges of pediatric liver disease is among those being honored at the American Liver Foundation’s (ALF) National Legacy Gala, being held Oct. 29 in New York. The Kellner family, who founded the Kellner Family Pediatric Liver Disease Foundation, will receive the […] The post Liver Foundation honors family who turned diagnosis into giving appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
One of the hardest parts of living with metabolic dysfunction-associated steatohepatitis (MASH) is carrying regrets about the past. The first time your doctor noticed your liver enzymes were elevated. The days of bone-deep fatigue after doing something you used to bounce back from, like gardening. The sudden swelling in your legs. The way favorite foods […] The post A new tool may help predict your future with liver disease appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
The American Liver Foundation (ALF) is launching a first-of-its kind national database, called the ALF Living Donor Network, to connect people willing to donate part of their liver to a stranger with patients for whom a liver transplant could be life-saving. “There are nearly 9,300 people in the United States waiting for a liver transplant […] The post ALF unveils network to connect living donors with strangers in need appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
A combination of pemafibrate and telmisartan, two medications approved in some countries to help manage cardiovascular conditions, may help reduce the buildup of liver fat in people with fatty liver disease, according to a study done in animal models. The study, “Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models […] The post Drug combo shrinks liver fat in rats and zebrafish: Study appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
October is National Liver Awareness Month and Liver Cancer Awareness Month, and advocacy organizations across the U.S., including the American Liver Foundation (ALF), are recognizing both by offering initiatives and programs aiming to help the estimated 100 million Americans living with some form of liver disease. Key to these efforts are education, identification, and prevention. […] The post Know your risks – and options – this National Liver Awareness Month appeared first on Liver Di...| Liver Disease News – The Web's Daily Resource for Liver Disease News
As leaves fall from the trees, columnist Kathryn Hudson celebrates the changes, both big and small, that have improved her health with MASH.| Liver Disease News
Roche is acquiring 89bio and its fatty liver disease therapy candidate pegozafermin, being tested for MASH in two global clinical trials.| Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
Eating healthy foods is vital with liver disease, but inflation can make this challenging. Columnist Kathryn Hudson shares her budget tips.| Liver Disease News
American Liver Foundation (ALF) Liver Life Challenge Global Ambassador, Jim Miller, has run each “centennial marathon” with ALF – 100, 200, and now he is heading full speed towards marathon #300. Learn more about Jim's quest to hit #300 with Liver Life Challenge Team ALF at the Boston Marathon this April and what he is doing to raise awareness for the liver community along the way.| American Liver Foundation
